Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 35Genitourinary 11Breast 11Classical hematology 9Thoracic 8Plasma cell 8Myeloid 7Gynecologic 6Tumor-Agnostic 4Head & Neck 3Dermatologic 3Sarcoma 2CNS 2Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Venous Thromboembolism 1Neuroma, Acoustic 1Neurofibromatosis 2 1Hematologic Diseases 1Glioblastoma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Aspirin × CNS × Clear all
NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Massachusetts Eye and Ear Infirmary

Phase 2 Active not recruiting
97 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT00790452 2011-12-08

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 1 chart
CNSClassical hematology

Glioblastoma, Hematologic Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡